Immuno-oncology company Aulos Bioscience has revealed interim results from an ongoing Phase I/II trial of monoclonal antibody AU-007 in solid tumours.
Read more here.
![[Ravin in ASBN] Ravin CEO Eliron Ekstein discusses the unique path to developing his entrepreneurial mindset](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Ravin in ASBN] Ravin CEO Eliron Ekstein discusses the unique path to developing his entrepreneurial mindset
January 15, 2021
[D-ID in The Financial Times] MyHeritage unveils AI tool that turns photos of dead relatives into videos
February 25, 2021
